Max Robotics — Global Service Robot Directory + US Certification

About

Dr. Tomoya Hatayama is a pioneering urologic surgeon whose research is reshaping the landscape of robotic-assisted oncology. His primary focus lies in the clinical application and optimization of advanced robotic platforms—most notably the hinotori™ Surgical Robot System—for complex urological tumor surgeries. Dr. Hatayama’s major contributions include establishing the safety and effectiveness of hinotori for procedures like robot-assisted radical prostatectomy (RARP) and partial nephrectomy, as detailed in his highly cited 2024 work. He has also made critical strides in improving patient quality of life, developing a risk classification system using detailed positive surgical margin status to predict biochemical recurrence, and identifying predictors of long-term postoperative urinary incontinence. His work on preoperative testosterone levels as a predictor of preserved sexual function after nerve-sparing RARP offers a novel, patient-centered approach to surgical planning. With over 28 citations across his most recent papers, Dr. Hatayama is also advancing comparative effectiveness research, demonstrating the superiority of robotic adrenalectomy over laparoscopic methods. His ongoing randomized trial on open-ended urinary catheters to prevent bladder discomfort underscores his commitment to refining every aspect of the surgical experience.